Customizing subcutaneous immunoglobulin administration in
primary antibody deficiency: patient-centric care perspectives

J 2024

Customizing subcutaneous immunoglobulin administration in primary antibody deficiency: patient-centric care perspectives

KOBAYASHI, Roger H; Joanna MALTESE; Jiří LITZMAN; Huub KREUWEL; Theresa ZEKOLL et al.

Základní údaje

Originální název

Customizing subcutaneous immunoglobulin administration in primary antibody deficiency: patient-centric care perspectives

Autoři

KOBAYASHI, Roger H; Joanna MALTESE; Jiří LITZMAN; Huub KREUWEL; Theresa ZEKOLL; Ai Lan KOBAYASHI a Sudhir GUPTA

Vydání

IMMUNOTHERAPY, London, FUTURE MEDICINE LTD, 2024, 1750-743X

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30102 Immunology

Stát vydavatele

Velká Británie a Severní Irsko

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Impakt faktor

Impact factor: 2.300

Označené pro přenos do RIV

Ano

Kód RIV

RIV/00216224:14110/24:00138628

Organizační jednotka

Lékařská fakulta

Klíčová slova anglicky

Immunoglobulin replacement therapy; patient-centric; primary antibody deficiency disease; shared decision-making; subcutaneous immunoglobulin; Cutaquig

Štítky

14110114, rivok

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 4. 4. 2025 13:28, Mgr. Tereza Miškechová

Anotace

V originále

This report delves into the challenges and potential solutions associated with flexible, customized subcutaneous immunoglobulin (SCIG) infusion regimens for patients with primary antibody deficiency disease (PAD). Advances in the treatment of inborn errors of immunity, particularly PAD, have converted fatal diseases into chronic, complex, long-term conditions that make adherence to treatment a critical issue. Conventional SCIG infusion regimens, while clinically effective, may not always align with the varied lifestyles, changing lifestyles and commitments of patients which can lead to missed doses, diminishing adherence thus posing potential health risks and compromising the overall effectiveness of treatment. For these reasons, it's important to develop flexible infusion regimens tailored to meet individual patient needs. Patient-centric strategies that promote shared decision-making and awareness of patient status not only promote medical efficacy but also enhance the overall patient experience. The authors of this report call attention for a need to shift toward more adaptable and individualized SCIG treatment plans for PAD patients whose needs may change over the long-term course of treatment.

Citovat

KOBAYASHI, Roger H; Joanna MALTESE; Jiří LITZMAN; Huub KREUWEL; Theresa ZEKOLL; Ai Lan KOBAYASHI a Sudhir GUPTA. Customizing subcutaneous immunoglobulin administration in primary antibody deficiency: patient-centric care perspectives. IMMUNOTHERAPY. London: FUTURE MEDICINE LTD, 2024, roč. 16, 20-22, s. 1235-1245. ISSN 1750-743X. Dostupné z: https://doi.org/10.1080/1750743X.2024.2436343.

@article{2471398,
   author = {Kobayashi, Roger H and Maltese, Joanna and Litzman, Jiří and Kreuwel, Huub and Zekoll, Theresa and Kobayashi, Ai Lan and Gupta, Sudhir},
   article_location = {London},
   article_number = {20-22},
   doi = {https://doi.org/10.1080/1750743X.2024.2436343},
   keywords = {Immunoglobulin replacement therapy; patient-centric; primary antibody deficiency disease; shared decision-making; subcutaneous immunoglobulin; Cutaquig},
   language = {eng},
   issn = {1750-743X},
   journal = {IMMUNOTHERAPY},
   title = {Customizing subcutaneous immunoglobulin administration in primary antibody deficiency: patient-centric care perspectives},
   url = {https://www.tandfonline.com/doi/full/10.1080/1750743X.2024.2436343},
   volume = {16},
   year = {2024}
}

TY  - JOUR
ID  - 2471398
AU  - Kobayashi, Roger H - Maltese, Joanna - Litzman, Jiří - Kreuwel, Huub - Zekoll, Theresa - Kobayashi, Ai Lan - Gupta, Sudhir
PY  - 2024
TI  - Customizing subcutaneous immunoglobulin administration in primary antibody deficiency: patient-centric care perspectives
JF  - IMMUNOTHERAPY
VL  - 16
IS  - 20-22
SP  - 1235-1245
EP  - 1235-1245
PB  - FUTURE MEDICINE LTD
SN  - 1750743X
KW  - Immunoglobulin replacement therapy
KW  - patient-centric
KW  - primary antibody deficiency disease
KW  - shared decision-making
KW  - subcutaneous immunoglobulin
KW  - Cutaquig
UR  - https://www.tandfonline.com/doi/full/10.1080/1750743X.2024.2436343
N2  - This report delves into the challenges and potential solutions associated with flexible, customized subcutaneous immunoglobulin (SCIG) infusion regimens for patients with primary antibody deficiency disease (PAD). Advances in the treatment of inborn errors of immunity, particularly PAD, have converted fatal diseases into chronic, complex, long-term conditions that make adherence to treatment a critical issue. Conventional SCIG infusion regimens, while clinically effective, may not always align with the varied lifestyles, changing lifestyles and commitments of patients which can lead to missed doses, diminishing adherence thus posing potential health risks and compromising the overall effectiveness of treatment. For these reasons, it's important to develop flexible infusion regimens tailored to meet individual patient needs. Patient-centric strategies that promote shared decision-making and awareness of patient status not only promote medical efficacy but also enhance the overall patient experience. The authors of this report call attention for a need to shift toward more adaptable and individualized SCIG treatment plans for PAD patients whose needs may change over the long-term course of treatment.
ER  -

KOBAYASHI, Roger H; Joanna MALTESE; Jiří LITZMAN; Huub KREUWEL; Theresa ZEKOLL; Ai Lan KOBAYASHI a Sudhir GUPTA. Customizing subcutaneous immunoglobulin administration in primary antibody deficiency: patient-centric care perspectives. \textit{IMMUNOTHERAPY}. London: FUTURE MEDICINE LTD, 2024, roč.~16, 20-22, s.~1235-1245. ISSN~1750-743X. Dostupné z: https://doi.org/10.1080/1750743X.2024.2436343.

Přehled o publikaci